Phase I Study of West Nile Virus Vaccine
NCT00300417
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
30
Enrollment
NIH
Sponsor class
Conditions
West Nile Fever
Interventions
DRUG:
VRC-WNVDNA020-00-VP
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)